Nuvation Bio Inc. - Common Stock (NUVB)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
339,200,672
Total 13F shares
151,280,175
Share change
+3,298,265
Total reported value
$1,503,381,648
Put/Call ratio
142%
Price per share
$9.94
Number of holders
97
Value change
+$33,688,697
Number of buys
52
Number of sells
37

Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q3 2021

As of 30 Sep 2021, Nuvation Bio Inc. - Common Stock (NUVB) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 151,280,175 shares. The largest 10 holders included FMR LLC, Omega Fund Management, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, BAUPOST GROUP LLC/MA, Avidity Partners Management LP, CITADEL ADVISORS LLC, BlackRock Inc., Redmile Group, LLC, and BOXER CAPITAL, LLC. This page lists 97 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.